# Efficacy and Safety of Arbidol in the Treatment of Allergic Rhinitis

> **NCT06462417** · NA · RECRUITING · sponsor: **Zheng Liu** · enrollment: 15 (estimated)

## Conditions studied

- Allergic Rhinitis

## Interventions

- **DRUG:** Arbidol

## Key facts

- **NCT ID:** NCT06462417
- **Lead sponsor:** Zheng Liu
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-11
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2025-05-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06462417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06462417, "Efficacy and Safety of Arbidol in the Treatment of Allergic Rhinitis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06462417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*